(Q33870235)

29 July 2017

1 reference

title

Drug-induced liver diseases. (English)

1 reference

29 July 2017

D Larrey

1

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

Journal of Hepatology

1 reference

29 July 2017

32

1 reference

29 July 2017

1 Suppl

1 reference

29 July 2017

77-88

1 reference

Hepatotoxicity of herbal remedies

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Hepatotoxicity of saccharin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

[Drug-induced hepatitis: epidemiologic, clinical, diagnostic and physiopathologic aspects in 1995]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Drug-induced immunotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Genetic predisposition to drug-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Polymorphism of dextromethorphan oxidation in a French population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Pharmacogenetic phenotyping and genotyping. Present status and future potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Genetically determined oxidation polymorphism and drug hepatotoxicity. Study of 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Criteria of drug-induced liver disorders. Report of an international consensus meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Drug-induced cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Drug-induced cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Prolonged cholestasis after ajmaline-induced acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Paracetamol-induced acute liver failure: prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Acute hepatitis after riluzole administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Molecular structure and hepatotoxicity: compared data about two closely related thiophene compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Tianeptine--an instance of drug-induced hepatotoxicity predicted by prospective experimental studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Use of hepatocyte cultures for the study of hepatotoxic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Simulation of human xenobiotic metabolism in microorganisms. Yeast a good compromise between E. coli and human cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

Hepatotoxicity in drug development: detection, significance and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980417-1

7 January 2021

10.1016/S0168-8278(00)80417-1

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10728796